Innovating Tomorrow: CellBios unveils its transformative bioprocess portfolio at INTERPHEX 2025

CellBios’ recent participation in INTERPHEX 2025, concluded at the Javits Center in New York City, stood as a testament to our transformative bioprocessing portfolio for advancing therapeutics. This premier event, held from April 1-3, drew the brightest minds and most innovative companies in the biopharmaceutical and biotechnology sectors, and we showcased how our cutting-edge bioprocessing technologies empower the industry.

At the core of CellBios’ exhibit were our CellStor® Bag Transfer Assemblies, a versatile system engineered to streamline the filling of critical biological materials—such as blood components, cell cultures, and biopharmaceutical solutions. Featuring kink-free tubing, high-strength seals, and customizable port configurations, these assemblies impressed attendees with their promise of safety, efficiency, and scalability. CellBios designed these solutions to address diverse needs, from small-scale research to large-volume production, underscoring our dedication to flexible bioprocessing.

Our expert team warmly welcomed visitors who stopped by our booth for live demonstrations. Enthusiasm and insightful questions from you were met with gratitude, reinforcing why these products are developed: workflows are to be streamlined, precision is to be elevated, and your path from lab to market is to be accelerated. Conversations about the future of therapeutic biomanufacturing were enriched by our contributions alongside other industry leaders—discussions poised to shape the solutions we continue to refine for you.

As INTERPHEX 2025 draws to a close, our bioprocess portfolio, praised for its forward-thinking design, has been established as a vital resource for researchers and manufacturers alike. Further advancements are expected to be closely monitored by the industry, with our INTERPHEX showcase having raised the bar for bioprocessing excellence.